Encephalopathy and bilateral thalamic lesions in a child with MIS-C associated with COVID-19
Citation Manager Formats
Make Comment
See Comments

Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, characterized predominantly by respiratory symptoms, has affected a small subset of children. Neurological manifestations have been described in adults, including encephalitis/meningitis, encephalopathy, strokes, seizures, and anosmia,1, 2 but there are few reports of neurologic manifestations in children with SARS-CoV-2.3
- Received June 16, 2020.
- Accepted in final form August 3, 2020.
- Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Letters: Rapid online correspondence
- Author response: Encephalopathy and bilateral thalamic lesions in a child with MIS-C associated with COVID-19
- Dori N. Abel, Pediatric Resident Physician, Columbia University Irving Medical Center, Department of Pediatrics; NewYork-Presbyterian Hospital
Submitted November 04, 2020 - Reader response: Encephalopathy and bilateral thalamic lesions in a child with MIS-C associated with COVID-19
- Calixto Machado, Senior Professor and Researcher in Neurology, Corresponding Fellow of the American Academy of Neurology, Institute of Neurology and Neurosurgery (Havana, Cuba)
Submitted October 27, 2020
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Review
Neurology and the COVID-19 PandemicGathering Data for an Informed ResponseBrigit High, Alison M. Hixon, Kenneth L. Tyler et al.Neurology: Clinical Practice, July 13, 2020 -
Views & Reviews
Presentations and mechanisms of CNS disorders related to COVID-19Marta Bodro, Yaroslau Compta, Raquel Sánchez-Valle et al.Neurology: Neuroimmunology & Neuroinflammation, December 11, 2020 -
Clinical/Scientific Notes
Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19Ahmed Elkady, Alejandro A. Rabinstein et al.Neurology: Neuroimmunology & Neuroinflammation, June 04, 2020 -
Article
Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong NeuroinflammationRaphael Bernard-Valnet, Sylvain Perriot, Mathieu Canales et al.Neurology: Neuroimmunology & Neuroinflammation, June 16, 2021